This study’s strengths are highlighted by the potential role of LAIR1 engagement by PTIC in leading in vitro M1 to M2 polarization through the downregulation of STAT1 phosphorylation and the replication of the effect in mild to moderate COVID-19 patients under treatment with PTIC. The gene discussed is STAT1; the disease is COVID-19.